AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 257: L318-L330, 1989;
1040-0605/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patterson, C. E.
Right arrow Articles by Rhoades, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patterson, C. E.
Right arrow Articles by Rhoades, R. A.

AJP - Lung Cellular and Molecular Physiology, Vol 257, Issue 6 318-L330, Copyright © 1989 by American Physiological Society


ARTICLES

Substrate utilization in the perinatal lung

C. E. Patterson and R. A. Rhoades
Department of Physiology and Biophysics, Indiana University School of Medicine, Indianapolis 46223.

Lung cellular metabolism is fundamental to both respiratory and nonrespiratory function. The lung has very little energy reserve and is highly dependent on circulating substrates. The pattern of substrate utilization is determined primarily substrate availability, competition between certain substrates, and the ability of lung cells for uptake and metabolism. The lung uses a number of substrates (glucose, lactate, fatty acids, choline, ketone bodies, and amino acids) as basic building blocks for synthesis, as energy-providing fuels, to provide NADPH for lipid biosynthesis, and for glutathione production. Since the availability of substrates, the cellular profile, the hormonal environment, and the physiological state of the lung are drastically altered during perinatal lung development, this review focuses on current knowledge of lung substrate utilization during this critical period. Because development of the surfactant system has been specifically linked to infant respiratory distress syndrome, the majority of investigations relate to substrate utilization for phospholipid synthesis. It is hoped that this review will outline basic principles for interpretation of information on perinatal substrate utilization, collate available data, and provide a stimulus for future research.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. E. H. BUNT, V. P. CARNIELLI, J. L. DARCOS WATTIMENA, W. C. HOP, P. J. J. SAUER, and L. J. I. ZIMMERMANN
The Effect in Premature Infants of Prenatal Corticosteroids on Endogenous Surfactant Synthesis as Measured with Stable Isotopes
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 844 - 849.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. HENSEL and W. J. KOX
Increased Intrapulmonary Oxygen Consumption in Mechanically Ventilated Patients with Pneumonia
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 137 - 143.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online